Open AccessCarfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
Author(s) -
Dominik Dytfeld,
Jagoda Jasielec,
Kent A. Griffith,
Daniel Lebovic,
David H. Vesole,
Sundar Jagannath,
Ammar Al-Zoubi,
Tara Anderson,
Kristen Detweiler-Short,
Keith Stockerl-Goldstein,
Asra Ahmed,
Terri L. Jobkar,
Diane E. Durecki,
Kathryn McDonnell,
Melissa A. Mietzel,
Daniel R. Couriel,
Mark Kaminski,
Ravi Vij,
Andrzej Jakubowiak
Publication year - 2014
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2014.110395
Subject(s) - carfilzomib , lenalidomide , multiple myeloma , thalidomide , melphalan , prednisone , bortezomib , medicine , dexamethasone , oncology , pharmacology